Role of C3d and C4d complement fragments in the diagnostics of acute allograft rejection after transplantations
- PMID: 20009158
Role of C3d and C4d complement fragments in the diagnostics of acute allograft rejection after transplantations
Abstract
Transplantation is a widely recognized method of treatment at the terminal stages of many renal, cardiac, hepatic and pulmonary diseases. Despite considerable advances in that field, graft rejection is still an important clinical problem. The reaction of the graft recipient to an organ presenting foreign antigens is dependent on complex immune mechanisms, involving both acquired and congenital immune responses. In most general terms, cellular and humoral immunity can be distinguished. The kidneys and the heart are the organs whose acute humoral rejection has been thoroughly investigated and defined, and the role of C4d and C3d fragments of the complement system has been confirmed by numerous studies. The studies concerning C4d and C3d expression in patients with acute humoral lung and liver rejection conducted to date have given contradictory results. Some of them confirm, while others fail to confirm, the correlation between their increased expression and AHR. From the practical point of view, C4d and C3d could be used in liver transplantology for differential diagnostics of acute graft rejection and recurrence of HCV infection. A few preliminary studies suggest the usefulness of these markers in the diagnostics of AMR and differentiation between both liver pathologies. There are only single reports concerning the role of C4d complement fragment in the diagnostics of acute rejection with a humoral component in case of small intestine grafts, as well as complex ones such as the hands and face, and their results suggests that these complement fragments are not important markers of acute rejection of these organs.
Comment in
-
C3d and C4d complement and graft rejection.Ann Transplant. 2010 Apr-Jun;15(2):76. Ann Transplant. 2010. PMID: 20657525 No abstract available.
Similar articles
-
C4d in acute rejection after liver transplantation and its usefulness in differential diagnosis between acute liver rejection and hepatitis C recurrence.Ann Transplant. 2014 Aug 1;19:373-81. doi: 10.12659/AOT.890234. Ann Transplant. 2014. PMID: 25082343
-
Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.Transpl Immunol. 2012 Jan;26(1):62-9. doi: 10.1016/j.trim.2011.08.005. Epub 2011 Sep 1. Transpl Immunol. 2012. PMID: 21907804
-
C4d staining of pulmonary allograft biopsies: an immunoperoxidase study.J Heart Lung Transplant. 2005 Oct;24(10):1565-70. doi: 10.1016/j.healun.2004.11.038. J Heart Lung Transplant. 2005. PMID: 16210131
-
Antibody-mediated rejection in the liver allograft.Curr Opin Organ Transplant. 2012 Jun;17(3):280-6. doi: 10.1097/MOT.0b013e328353584c. Curr Opin Organ Transplant. 2012. PMID: 22569512 Review.
-
Immune response and histology of humoral rejection in kidney transplantation.Nefrologia. 2016 Jul-Aug;36(4):354-67. doi: 10.1016/j.nefro.2016.03.023. Epub 2016 Jun 3. Nefrologia. 2016. PMID: 27267916 Review. English, Spanish.
Cited by
-
Dynamic expression of Qa-2 during acute graft rejection.Mol Med. 2011 Mar-Apr;17(3-4):248-55. doi: 10.2119/molmed.2010.00133. Epub 2010 Nov 12. Mol Med. 2011. PMID: 21079885 Free PMC article.
-
The Diagnostic Significance of C3d Antigen in Kidney and Skin Histopathology - The Current State-Of-The-Art and Practical Examples.Physiol Res. 2023 Oct 27;72(S3):S225-S232. doi: 10.33549/physiolres.935175. Physiol Res. 2023. PMID: 37888966 Free PMC article. Review.
-
The continual presence of C3d but not IgG glomerular capillary deposition in stage I idiopathic membranous nephropathy in patients receiving corticosteroid treatment.Diagn Pathol. 2012 Aug 21;7:109. doi: 10.1186/1746-1596-7-109. Diagn Pathol. 2012. PMID: 22909298 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical